首页> 外文OA文献 >A Pilot Study of T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation With Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients With Relapsed Multiple Myeloma and High-Risk Cytogenetics

【2h】

A Pilot Study of T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation With Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients With Relapsed Multiple Myeloma and High-Risk Cytogenetics

机译：丁硫丹，美法仑和氟达拉滨调理T细胞贫血异基因造血干细胞移植后再行移植后供体淋巴细胞输注治疗复发性多发性骨髓瘤和高危细胞遗传学的先导研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Koehne G.; Landau H.; Hassoun H.; Lesokhin A.; Lendvai N.; Rosenzweig M.; Chung D.J.; Young J.W.; Giralt S.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions [J] . Blood: The Journal of the American Society of Hematology . 2013,第2期

机译：高危多发性骨髓瘤患者接受同种异体T细胞的造血干细胞移植和供体淋巴细胞输注的WT1特异性T细胞反应
2. WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell-depleted hematopoietic stem cell transplantation and donor lymphocyte infusions [J] . Blood: The Journal of the American Society of Hematology . 2013,第2期

机译：高危多发性骨髓瘤患者接受同种异体T细胞的造血干细胞移植和供体淋巴细胞输注的WT1特异性T细胞反应
3. Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma [J] . El-CheikhJ., CrocchioloR., FurstS., Experimental Hematology: Official Publication of the International Society for Experimental Hematology . 2012,第7期

机译：高危多发性骨髓瘤患者异体干细胞移植后加来那度胺加供体淋巴细胞的强度降低
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. WT1-specific T-cell responses in high-risk multiple myeloma patients undergoing allogeneic T cell–depleted hematopoietic stem cell transplantation and donor lymphocyte infusions [O] . Eleanor M. Tyler, Achim A. Jungbluth, Richard J. OReilly, -1

机译：高危多发性骨髓瘤患者接受同种异体T细胞的造血干细胞移植和供体淋巴细胞输注的WT1特异性T细胞反应
7. WT1-Specific T-Cell Responses Following T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation and Donor Lymphocyte Infusions in Patients with High-Risk Multiple Myeloma [O] . Tyler E., Jungbluth A.A., OReilly R.J., 2012

机译：高危多发性骨髓瘤患者中T细胞贫乏的异基因造血干细胞移植和供体淋巴细胞输注后的WT1特异性T细胞反应。

A Pilot Study of T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation With Busulfan, Melphalan, and Fludarabine Conditioning Followed by Post Transplantation Donor Lymphocyte Infusions for Patients With Relapsed Multiple Myeloma and High-Risk Cytogenetics

著录项

引文网络

相似文献

相关主题

期刊订阅